Management of Waldenstrom disease: an update
49:06
Post #ASH24 Most Important CLL Studies
7:09
BeiGene Patient Perspective: Living with Waldenström’s Macroglobulinemia
43:48
Post #ASH24 Most Important Cellular Therapy Studies
58:40
Myélome multiple: traitements de la rechute hors immunothérapie (French)
53:00
Multiple Myeloma: Highlights from #ASH24
18:23
From the wilderness into the promised land…
43:43
Post #ASH24: the Most Important MPN Studies
55:10